Jonathan Smiga
Managing Partner @ KEEN Growth Capital
Orlando, United States
Jonathan Smiga is a Series A investor at KEEN Growth Capital in Orlando focused on Wellness and Health Care. Jonathan Smiga is the Managing Partner at KEEN Growth Capital. He attended Cornell University and NYU Stern School of Business.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jonathan Smiga invests in
Stages Jonathan Smiga invests in
Countries Jonathan Smiga invests in
Investment Focus
Industry
- Wellness 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Food and Beverage 1 (50%)
Stage
- Series A 1 (50%)
- Venture - Series Unknown 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Healthycell
|
Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $1.6M / Series A / Sep 14, 2021 | |
|
Healthycell
|
Healthycell is based on the simple idea that nutrients need to be absorbed into the bloodstream and then into cells where they work to improve health. But most supplements use the same pill-form delivery technologies that were around in the 1930's, back when we were using rotary phones! Our nutrient delivery technologies have not kept pacewith the innovation of other industries. Decades of lab work show that most pills (and even powders) have low absorption. These older delivery systems compress dehydrated, large, dense, insoluble particles that are 10x to 100x too big for absorption through the small intestine where the human body absorbs most nutrients. That's why we forced the evolution of nutrition supplements with MICROGEL™. | $1.6M / Venture - Series Unknown / Sep 14, 2021 |
Co-Investors
About KEEN Growth Capital
KEEN paves the way for early stage impact brands to flourish. KEEN Growth Capital identifies food, beverage and wellness companies with great potential started by revolutionary-thinking, passionate entrepreneurs. The firm applies trusted skill and passion to develop portfolio brands into highly successful and respected companies. Infusion ofintellectual and financial capital delivers positive outcomes for stakeholders - and ultimately the consumer. Investors benefit from outstanding returns and society is enriched by healthier products.
KEEN Growth Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jonathan Smiga
Managing Partner
|
|||
David Comeau
Venture Partner
|
|||
Donna Spence
CFO
|
|||
Jerry Bello
Co-Founder, Managing Partner & CEO
|
|||
Robert Althuis
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jonathan Smiga invest in?
Jonathan Smiga invests primarily in Wellness, Health Care and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jonathan Smiga last invest?
The most recent investment recorded for Jonathan Smiga closed in Sep 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
